Back to Search
Start Over
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420
- Source :
- Science, Science, 2017, 355 (6330), pp.1206-1211. ⟨10.1126/science.aag1006⟩, Science, American Association for the Advancement of Science, 2017, 355 (6330), pp.1206-1211. ⟨10.1126/science.aag1006⟩
- Publication Year :
- 2017
- Publisher :
- American Association for the Advancement of Science (AAAS), 2017.
-
Abstract
- Countering TB prodrug resistance The arsenal of antibiotics for treating tuberculosis (TB) contains many prodrugs, such as ethionamide, which need activation by normal metabolism to release their toxic effects. Ethionamide is potentiated by small molecules. Blondiaux et al. screened for more potent analogs and identified a lead compound called SMARt-420. This small molecule inactivates a TetR-like repressor, EthR2, and boosts ethionamide activation. SMARt-420 successfully promoted clearance of multidrug-resistant strains of Mycobacterium tuberculosis from the lungs of mice. Science , this issue p. 1206
- Subjects :
- 0301 basic medicine
Tuberculosis
medicine.drug_class
[CHIM.THER] Chemical Sciences/Medicinal Chemistry
030106 microbiology
Antibiotics
Reversion
[CHIM.THER]Chemical Sciences/Medicinal Chemistry
Microbiology
Mycobacterium tuberculosis
03 medical and health sciences
Antibiotic resistance
[CHIM] Chemical Sciences
medicine
[CHIM]Chemical Sciences
chemistry.chemical_classification
Multidisciplinary
biology
medicine.disease
biology.organism_classification
3. Good health
030104 developmental biology
Enzyme
chemistry
Ethionamide
Bacteria
medicine.drug
Subjects
Details
- ISSN :
- 10959203 and 00368075
- Volume :
- 355
- Database :
- OpenAIRE
- Journal :
- Science
- Accession number :
- edsair.doi.dedup.....40ed76165230b886b92d460b21abcf17